Souhaila H. El Moukhtari - Publications

Oral solid lipid nanoparticles of etoposide enable metronomic-like therapy with reduced toxicity in MYCN-amplified neuroblastoma.

Journal: Cancer letters

Published: January 30, 2026

Correction: Biosafety evaluation of etoposide lipid nanomedicines in C. elegans.

Journal: Drug delivery and translational research

Published: March 08, 2024

RNA-loaded nanoparticles for the treatment of hematological cancers.

Journal: Advanced drug delivery reviews

Published: February 19, 2024

Lipid nanoparticles for siRNA delivery in cancer treatment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 16, 2023

Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 12, 2022

In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: January 14, 2022

Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.

Journal: International journal of pharmaceutics

Published: June 03, 2021

Oral lipid nanomedicines: Current status and future perspectives in cancer treatment.

Journal: Advanced drug delivery reviews

Published: January 07, 2021